ArticleBMJ open2019

Correction: Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.